These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
953 related articles for article (PubMed ID: 11120766)
1. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. den Haan JM; Lehar SM; Bevan MJ J Exp Med; 2000 Dec; 192(12):1685-96. PubMed ID: 11120766 [TBL] [Abstract][Full Text] [Related]
2. Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo. Ho NI; Camps MGM; de Haas EFE; Ossendorp F Eur J Immunol; 2018 Jul; 48(7):1164-1173. PubMed ID: 29676785 [TBL] [Abstract][Full Text] [Related]
3. Dendritic cell maturation enhances CD8+ T-cell responses to exogenous antigen via a proteasome-independent mechanism of major histocompatibility complex class I loading. Robson NC; Beacock-Sharp H; Donachie AM; Mowat AM Immunology; 2003 Jul; 109(3):374-83. PubMed ID: 12807483 [TBL] [Abstract][Full Text] [Related]
4. The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. Schnorrer P; Behrens GM; Wilson NS; Pooley JL; Smith CM; El-Sukkari D; Davey G; Kupresanin F; Li M; Maraskovsky E; Belz GT; Carbone FR; Shortman K; Heath WR; Villadangos JA Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10729-34. PubMed ID: 16807294 [TBL] [Abstract][Full Text] [Related]
5. CD8alpha- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8alpha and CD205 molecules. Morón G; Rueda P; Casal I; Leclerc C J Exp Med; 2002 May; 195(10):1233-45. PubMed ID: 12021304 [TBL] [Abstract][Full Text] [Related]
6. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105 [TBL] [Abstract][Full Text] [Related]
7. Thymic but not splenic CD8⁺ DCs can efficiently cross-prime T cells in the absence of licensing factors. Dresch C; Ackermann M; Vogt B; de Andrade Pereira B; Shortman K; Fraefel C Eur J Immunol; 2011 Sep; 41(9):2544-55. PubMed ID: 21748731 [TBL] [Abstract][Full Text] [Related]
8. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. Pooley JL; Heath WR; Shortman K J Immunol; 2001 May; 166(9):5327-30. PubMed ID: 11313367 [TBL] [Abstract][Full Text] [Related]
9. A marked reduction in priming of cytotoxic CD8+ T cells mediated by stress-induced glucocorticoids involves multiple deficiencies in cross-presentation by dendritic cells. Hunzeker JT; Elftman MD; Mellinger JC; Princiotta MF; Bonneau RH; Truckenmiller ME; Norbury CC J Immunol; 2011 Jan; 186(1):183-94. PubMed ID: 21098225 [TBL] [Abstract][Full Text] [Related]
10. Highly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient mice. Apasov S; Sitkovsky M Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2837-41. PubMed ID: 8464897 [TBL] [Abstract][Full Text] [Related]
11. Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression. McLellan AD; Kapp M; Eggert A; Linden C; Bommhardt U; Bröcker EB; Kämmerer U; Kämpgen E Blood; 2002 Mar; 99(6):2084-93. PubMed ID: 11877283 [TBL] [Abstract][Full Text] [Related]
12. Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo. den Haan JM; Bevan MJ J Exp Med; 2002 Sep; 196(6):817-27. PubMed ID: 12235214 [TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility complex class I-specific and -restricted killing of beta 2-microglobulin-deficient cells by CD8+ cytotoxic T lymphocytes. Glas R; Franksson L; Ohlén C; Höglund P; Koller B; Ljunggren HG; Kärre K Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11381-5. PubMed ID: 1454824 [TBL] [Abstract][Full Text] [Related]
14. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity. De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380 [TBL] [Abstract][Full Text] [Related]
15. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. Porgador A; Gilboa E J Exp Med; 1995 Jul; 182(1):255-60. PubMed ID: 7540653 [TBL] [Abstract][Full Text] [Related]
16. Stroma-dependent development of two dendritic-like cell types with distinct antigen presenting capability. Periasamy P; O'Neill HC Exp Hematol; 2013 Mar; 41(3):281-92. PubMed ID: 23178375 [TBL] [Abstract][Full Text] [Related]
17. CTL priming by CD8(+) and CD8(-) dendritic cells in vivo. Ruedl C; Bachmann MF Eur J Immunol; 1999 Nov; 29(11):3762-7. PubMed ID: 10556833 [TBL] [Abstract][Full Text] [Related]
18. Unique functions of splenic CD8alpha+ dendritic cells during infection with intracellular pathogens. Neuenhahn M; Busch DH Immunol Lett; 2007 Dec; 114(2):66-72. PubMed ID: 17964665 [TBL] [Abstract][Full Text] [Related]
19. Effective collaboration between marginal metallophilic macrophages and CD8+ dendritic cells in the generation of cytotoxic T cells. Backer R; Schwandt T; Greuter M; Oosting M; Jüngerkes F; Tüting T; Boon L; O'Toole T; Kraal G; Limmer A; den Haan JM Proc Natl Acad Sci U S A; 2010 Jan; 107(1):216-21. PubMed ID: 20018690 [TBL] [Abstract][Full Text] [Related]